Home » Topics » Conferences

Conferences
RSS

Candidate treatment for atopic dermatitis presented at Japanese congress

Nov. 2, 1999

CGS-35066: potent and specific ECE inhibitor presented at ET-6

Nov. 2, 1999

Abbott's ETA antagonist may also be indicated for diabetic nephropathy

Oct. 29, 1999

ETA/ETB antagonist tezosentan is a promising parenteral treatment for acute conditions

Oct. 29, 1999

Hydroxyurea tested as an alternative to PI in combination regimens in antiretroviral-naive subjects

Oct. 29, 1999

Dual-function anti-HIV microbicides/spermicidal agents still a focus at Hughes Institute

Oct. 29, 1999

More promising results with abarelix in endometriosis

Oct. 28, 1999

Mycophenolate mofetil in the treatment of refractory uveitis

Oct. 28, 1999

AGN-192024 is better than latanoprost for lowering diurnal IOP

Oct. 28, 1999

Once-daily s.c. T-1249 may provide therapeutic levels in man according to animal data

Oct. 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...